Given that it is therefore likely that no decision on the renewal of the approval of those active substances can be taken before the expiry of their respective approval periods on 15 November 2024, 30 November 2024 and 15 December 2024, and that the reasons for the delays in the renewal procedures are beyond the control of the respective applicants, the approval periods of those active substances should be extended in order to enable the completion of the assessments required and to finalise the respective procedures on renewal of approval.
Recital 11, Regulation (EU) 2024/2221
In forcesince 6 Sep 2024